Part 14 of a series on how the globalized world economy affects ordinary people. This program examines why AIDS drugs are unaffordable in developing countries, using as examples Thailand and South Africa, two countries who have applied to use compulsory licenses and parallel importing -- practices agreed under World Trade Organization guidelines -- to make their own generic versions of anti-retroviral drugs to halt the AIDS epidemic in their countries. It also asks why anti-retroviral drugs still aren't included in the WTO's essential drugs lists.
The information below has been drawn from sources outside of the University of Wisconsin-Madison Libraries. In most instances, the information will be from sources that have not been peer reviewed by scholarly or research communities. Please report cases in which the information is inaccurate through the Contact Us link below.